Antisense modulation of estrogen receptor alpha expression

The present invention provides compositions and methods for modulating the expression of estrogen receptor alpha. In particular, this invention relates to compounds, particularly oligonucleotides, specifically hybridizable with nucleic acids encoding estrogen receptor alpha. Such compounds have been...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Dobie, Kenneth W, Roach, Mark P
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Dobie, Kenneth W Roach, Mark P
description	The present invention provides compositions and methods for modulating the expression of estrogen receptor alpha. In particular, this invention relates to compounds, particularly oligonucleotides, specifically hybridizable with nucleic acids encoding estrogen receptor alpha. Such compounds have been shown to modulate the expression of estrogen receptor alpha. Antisense compounds, compositions and methods are provided for modulating the expression of estrogen receptor alpha. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding estrogen receptor alpha. Methods of using these compounds for modulation of estrogen receptor alpha expression and for treatment of diseases associated with expression of estrogen receptor alpha are provided.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06617162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06617162</sourcerecordid><originalsourceid>FETCH-uspatents_grants_066171623</originalsourceid><addsrcrecordid>eNrjZLByzCvJLE7NK05VyM1PKc1JLMnMz1PIT1NILS4pyk9PzVMoSk1OLSjJL1JIzCnISFRIrSgoSi0uBqriYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDMzNDc0MzImAglAJU2MKU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antisense modulation of estrogen receptor alpha expression</title><source>USPTO Issued Patents</source><creator>Dobie, Kenneth W ; Roach, Mark P</creator><creatorcontrib>Dobie, Kenneth W ; Roach, Mark P ; ISIS Pharmaceuticals, Inc</creatorcontrib><description>The present invention provides compositions and methods for modulating the expression of estrogen receptor alpha. In particular, this invention relates to compounds, particularly oligonucleotides, specifically hybridizable with nucleic acids encoding estrogen receptor alpha. Such compounds have been shown to modulate the expression of estrogen receptor alpha. Antisense compounds, compositions and methods are provided for modulating the expression of estrogen receptor alpha. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding estrogen receptor alpha. Methods of using these compounds for modulation of estrogen receptor alpha expression and for treatment of diseases associated with expression of estrogen receptor alpha are provided.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6617162$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6617162$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dobie, Kenneth W</creatorcontrib><creatorcontrib>Roach, Mark P</creatorcontrib><creatorcontrib>ISIS Pharmaceuticals, Inc</creatorcontrib><title>Antisense modulation of estrogen receptor alpha expression</title><description>The present invention provides compositions and methods for modulating the expression of estrogen receptor alpha. In particular, this invention relates to compounds, particularly oligonucleotides, specifically hybridizable with nucleic acids encoding estrogen receptor alpha. Such compounds have been shown to modulate the expression of estrogen receptor alpha. Antisense compounds, compositions and methods are provided for modulating the expression of estrogen receptor alpha. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding estrogen receptor alpha. Methods of using these compounds for modulation of estrogen receptor alpha expression and for treatment of diseases associated with expression of estrogen receptor alpha are provided.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZLByzCvJLE7NK05VyM1PKc1JLMnMz1PIT1NILS4pyk9PzVMoSk1OLSjJL1JIzCnISFRIrSgoSi0uBqriYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDMzNDc0MzImAglAJU2MKU</recordid><startdate>20030909</startdate><enddate>20030909</enddate><creator>Dobie, Kenneth W</creator><creator>Roach, Mark P</creator><scope>EFH</scope></search><sort><creationdate>20030909</creationdate><title>Antisense modulation of estrogen receptor alpha expression</title><author>Dobie, Kenneth W ; Roach, Mark P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_066171623</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Dobie, Kenneth W</creatorcontrib><creatorcontrib>Roach, Mark P</creatorcontrib><creatorcontrib>ISIS Pharmaceuticals, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dobie, Kenneth W</au><au>Roach, Mark P</au><aucorp>ISIS Pharmaceuticals, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antisense modulation of estrogen receptor alpha expression</title><date>2003-09-09</date><risdate>2003</risdate><abstract>The present invention provides compositions and methods for modulating the expression of estrogen receptor alpha. In particular, this invention relates to compounds, particularly oligonucleotides, specifically hybridizable with nucleic acids encoding estrogen receptor alpha. Such compounds have been shown to modulate the expression of estrogen receptor alpha. Antisense compounds, compositions and methods are provided for modulating the expression of estrogen receptor alpha. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding estrogen receptor alpha. Methods of using these compounds for modulation of estrogen receptor alpha expression and for treatment of diseases associated with expression of estrogen receptor alpha are provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_grants_06617162
source	USPTO Issued Patents
title	Antisense modulation of estrogen receptor alpha expression
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A48%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dobie,%20Kenneth%20W&rft.aucorp=ISIS%20Pharmaceuticals,%20Inc&rft.date=2003-09-09&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06617162%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true